3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
10
Phase 3
2
Status
Terminated
1
Completed
1
Sponsor Class
OTHER
2
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Thoracic
2
Conditions
Breast Neoplasms
551
Colorectal Neoplasms
246
Neoplasms
232
Prostatic Neoplasms
221
Carcinoma, Non-Small-Cell Lung
196
Stomach Neoplasms
153
Leukemia, Myeloid, Acute
149
Carcinoma, Hepatocellular
147
Lung Neoplasms
136
Rectal Neoplasms
135
Multiple Myeloma
132
Nasopharyngeal Carcinoma
111
Colonic Neoplasms
106
Neoplasm Metastasis
100
Precursor Cell Lymphoblastic Leukemia-Lymphoma
86
Lymphoma
85
Uterine Cervical Neoplasms
83
Pancreatic Neoplasms
82
Lymphoma, Large B-Cell, Diffuse
79
Ovarian Neoplasms
78
Leukemia
78
Head and Neck Neoplasms
77
Esophageal Neoplasms
74
Lymphoma, Follicular
72
Brain Neoplasms
70
Squamous Cell Carcinoma of Head and Neck
65
Recurrence
64
Leukemia, Lymphocytic, Chronic, B-Cell
59
Lymphoma, Non-Hodgkin
58
Pain
56
Interventions
Gemcitabine
2
Vinorelbine
1
Erlotinib Hydrochloride
1
Docetaxel
1
Cisplatin
1
Capecitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 3
×
OTHER
×
Advanced Non-Small Cell Lung Cancer
×
Clear all
NCT00349219
2016-01-15
TORCH
National Cancer Institute, Naples
Phase 3
Completed
760 enrolled
NCT00345059
2016-01-14
DISTAL-2
National Cancer Institute, Naples
Phase 3
Terminated
84 enrolled